Synthesis of human molecules by foreign organisms for pharmaceutical purposes

The insertion of insulin-producing genes into bacteria enabled cheaper, large-scale production of insulin hormone.

A 2019 report valued the market in therapeutics, mostly arising through recombinant genetic technologies, at more than US$315 billion.

1. The biggest fear about genetic engineering of medicaments is that it would be used for social purposes and not medical purposes.

1. Unethical pharmaceutical practices
2. Irresponsible genetic manipulation

1. Genetically modified RNA-vaccines

1. Overuse of hormone replacement therapy
2. Hormone pollution
3. Environmental hazards of pharmaceutical products
4. Abuse of performance enhancing drugs

1. Ineffective self-regulation in the pharmaceutical and medical devices industries
2. Illness requiring hormone replacement therapy

1. Male mid-life crisis

1. Untested use of hormones
2. Non-responsiveness of transnational corporations to pharmaceutical needs

1. Synthesis
2. Rights
3. Inhumanity
4. Foreign
5. Cross-purposes
6. Artificiality